Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Operating Leases (2022 - 2023)

Cullinan Therapeutics has reported Operating Leases over the past 2 years, most recently at $2.4 million for Q3 2023.

  • Quarterly results put Operating Leases at $2.4 million for Q3 2023, down 38.73% from a year ago — trailing twelve months through Sep 2023 was $2.4 million (down 38.73% YoY), and the annual figure for FY2022 was $3.6 million, changed.
  • Operating Leases for Q3 2023 was $2.4 million at Cullinan Therapeutics, down from $2.7 million in the prior quarter.
  • Over the last five years, Operating Leases for CGEM hit a ceiling of $4.0 million in Q3 2022 and a floor of $596000.0 in Q2 2022.